Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -3.96% | 58.19 | 0.0% | $1899.37m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.26% | 597.00 | 2.5% | $1174.48m | |
| GILD | Gilead Sciences, Inc. | -1.02% | 76.75 | 1.0% | $975.82m | |
| AMGN | Amgen, Inc. | 2.17% | 225.67 | 1.3% | $660.44m | |
| NVAX | Novavax, Inc. | 3.67% | 46.30 | 102.0% | $655.72m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -2.61% | 265.69 | 1.9% | $544.78m | |
| ILMN | Illumina, Inc. | -1.20% | 354.11 | 3.5% | $388.06m | |
| BIIB | Biogen, Inc. | 2.36% | 306.72 | 1.6% | $378.26m | |
| SRNE | Sorrento Therapeutics, Inc. | 6.74% | 4.12 | 1.8% | $269.11m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.35% | 115.21 | 2.0% | $241.70m | |
| SGEN | Seattle Genetics, Inc. | -1.36% | 148.39 | 6.1% | $223.95m | |
| A | Agilent Technologies, Inc. | -0.83% | 90.38 | 1.6% | $215.81m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.59% | 105.80 | 4.3% | $184.97m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.06% | 147.99 | 13.9% | $156.63m | |
| INCY | Incyte Corp. | -0.31% | 93.51 | 2.5% | $153.41m |
Company Profile
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.